Among our studied parameters, serum glutamic-pyruvic transaminase (SGPT) was observed to be high in 55.8% of individuals which may indicate the onset of non-alcoholic fatty liver disease (NAFLD)50. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.